Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PAX compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name
PAX
Patria Investments Ltd
Change
Mkt cap
Revenue
Revenue
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
PAX
Patria Investments Ltd
vs
TAK
Takeda Pharmaceutical Co Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PAX
13
—
KPMG Auditores Independentes Ltda
unlisted
supplier
—
Maples Corporate Services
unlisted
supplier
—
Nasdaq Global Select Market
unlisted
supplier
—
The Depository Trust
unlisted
supplier
9 more · PAX chain
›
Shared
0
No shared counterparties.
Only TAK
17
NBIX
Neurocrine Biosciences
customer
EXEL
Exelixis
supplier
PTGX
Protagonist Therapeutics
supplier
DNLI
Denali Therapeutics
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
13 more · TAK chain
›
PAX
Patria Investments Ltd
Change
9.18
▼
−1.29%
· post 9.18
Mkt cap
$1.5B
TAK
Takeda Pharmaceutical Co Ltd
Change
20.92
▲
+4.55%
· post 20.93
Closed
Oct 30 '26
Mkt cap
$36.0B
vs
Compare
Closed
Oct 30 '26
PAX
Patria Investments Ltd
vs
TAK
Takeda Pharmaceutical Co Ltd
9.18
▼
−1.29%
post 9.18
Price
20.92
▲
+4.55%
post 20.93
$1.5B
Mkt cap
$36.0B
Change
Change
PAX
9.18
▼
−1.29%
vs
TAK
20.92
▲
+4.55%
Closed
Oct 30 '26